Yahoo Web Search

  1. A couple of board chairs increased their stakes last week. Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price ...

  2. 4 Big Drugmakers Boasting Impressive Oncology Pipelines

    Zacks via Yahoo FinanceSep 11 13:32 PM

    Allied Market Research estimates the global cancer drugs market to be worth more than $176 billion by 2025. Companies focused on making innovative cancer drugs are in great demand for buyouts ...

  3. This excerpt was brought to you using the Research Reports feature available through Yahoo Finance Premium. and step up your investing. Analysts at Argus/Vickers highlighted several companies with sizeable new Buy Transactions in the past five days.

  4. Vertex Pharmaceuticals Incorporated VRTX announced that it has received a reimbursement approval in Scotland for its cystic fibrosis (CF) medicines Orkambi and Symkevi. Following this, approximately ...

  5. Top Insider Buys Highlight for the Week of Sept. 20

    GuruFocus.com via Yahoo FinanceSep 21 21:22 PM

    (NASDAQ:KHC), Dominion Energy Inc. (NYSE:D), Keurig Dr Pepper Inc. (NYSE:KDP) and AbbVie Inc. (NYSE:ABBV). Kraft Heinz director bought 250,000 shares Director Alexandre ...

  6. Dividend Growth ETFs for Long Term Investors

    Zacks via Yahoo FinanceSep 13 19:29 PM

    (JPM) : Free Stock Analysis Report AbbVie Inc. (ABBV) : Free Stock Analysis Report AT&T Inc. (T) : Free Stock Analysis Report Apple Inc. (AAPL) : Free ...

  7. Weekly Top Insider Buys Highlight for the Week of Sept. 6

    GuruFocus.com via Yahoo FinanceSep 08 21:04 PM

    The largest Insider Buys this week were for AbbVie Inc. (ABBV), Keurig Dr Pepper Inc. (KDP), Corteva Inc. (CTVA) and Fox Corp. (FOX). Continue reading...

  8. The combination of two of the world's biggest pharmaceutical companies, which was announced in June, would feature a portfolio that includes the world's top-selling...

  9. 3 Special Situations Gurus Are Buying

    GuruFocus.com via Yahoo FinanceSep 05 20:51 PM

    I spend a lot of time looking at merger and acquisition deals and special situations, like liquidations, because I feel cautious given market valuations. It is very important the company reserves ...

  10. A month has gone by since the last earnings report for Momenta Pharmaceuticals (MNTA). The company reported a loss of $1.16 per share in the quarter, wider than the Zacks Consensus Estimate ...

  1. Ads
    related to AbbVie Inc